Healthcare provider profile · identity verified

Francis X Mccann, MD

Internal Medicine · MENOMONEE FALLS, WI · NPI 1528090776

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	644	168
Omeprazole	Omeprazole	408	98
Amlodipine Besylate	Amlodipine Besylate	342	90
Losartan Potassium	Losartan Potassium	336	87
Levothyroxine Sodium	Levothyroxine Sodium	313	74
Lisinopril	Lisinopril	291	68
Pantoprazole Sodium	Pantoprazole Sodium	254	64
Gabapentin	Gabapentin	253	70
Hydrochlorothiazide	Hydrochlorothiazide	237	64
Simvastatin	Simvastatin	235	53
Warfarin Sodium	Warfarin Sodium	180	39
Trazodone Hcl	Trazodone Hcl	177	46
Furosemide	Furosemide	172	49
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	172	52
Fluoxetine Hcl	Fluoxetine Hcl	154	30
Tamsulosin Hcl	Tamsulosin Hcl	148	39
Alprazolam	Alprazolam	143	30
Eliquis	Apixaban	138	28
Metoprolol Succinate	Metoprolol Succinate	135	38
Metoprolol Tartrate	Metoprolol Tartrate	134	36
Spironolactone	Spironolactone	133	31
Albuterol Sulfate Hfa	Albuterol Sulfate	132	48
Allopurinol	Allopurinol	122	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	25
Metformin Hcl	Metformin Hcl	118	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	117	30
Lorazepam	Lorazepam	110	20
Meloxicam	Meloxicam	105	33
Methylprednisolone	Methylprednisolone	105	75
Ropinirole Hcl	Ropinirole Hcl	105	34
Tizanidine Hcl	Tizanidine Hcl	97	32
Sertraline Hcl	Sertraline Hcl	87	20
Clonazepam	Clonazepam	84	16
Clonidine Hcl	Clonidine Hcl	84	22
Prednisone	Prednisone	84	29
Metformin Hcl Er	Metformin Hcl	81	23
Glipizide	Glipizide	80	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	17
Montelukast Sodium	Montelukast Sodium	74	18
Clopidogrel	Clopidogrel Bisulfate	73	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	72	17
Rosuvastatin Calcium	Rosuvastatin Calcium	72	22
Tramadol Hcl	Tramadol Hcl	70	21
Zolpidem Tartrate	Zolpidem Tartrate	65	15
Alendronate Sodium	Alendronate Sodium	64	suppressed
Diazepam	Diazepam	64	15
Potassium Chloride	Potassium Chloride	64	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	19
Atenolol	Atenolol	58	15
Finasteride	Finasteride	58	15
Xarelto	Rivaroxaban	58	suppressed
Carvedilol	Carvedilol	57	16
Hydralazine Hcl	Hydralazine Hcl	52	11
Ozempic	Semaglutide	50	suppressed
Nifedipine Er	Nifedipine	47	suppressed
Pravastatin Sodium	Pravastatin Sodium	47	12
Ipratropium Bromide	Ipratropium Bromide	46	13
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	44	suppressed
Azithromycin	Azithromycin	43	34
Fluticasone Propionate	Fluticasone Propionate	43	15
Triamcinolone Acetonide	Triamcinolone Acetonide	43	28
Glimepiride	Glimepiride	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	27
Diclofenac Sodium	Diclofenac Sodium	38	18
Donepezil Hcl	Donepezil Hcl	37	suppressed
Famotidine	Famotidine	36	13
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	26
Buspirone Hcl	Buspirone Hcl	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	22
Propranolol Hcl	Propranolol Hcl	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Valsartan	Valsartan	26	suppressed
Digoxin	Digoxin	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Amoxicillin	Amoxicillin	24	19
Synthroid	Levothyroxine Sodium	24	suppressed
Baclofen	Baclofen	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Clonidine	Clonidine	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	13
Latanoprost	Latanoprost	17	suppressed
Metolazone	Metolazone	17	suppressed
Temazepam	Temazepam	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Torsemide	Torsemide	15	suppressed
Estradiol	Estradiol	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Metronidazole	Metronidazole	13	12
Nitroglycerin Patch	Nitroglycerin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Cephalexin	Cephalexin	12	12
Methocarbamol	Methocarbamol	12	suppressed
Risperidone	Risperidone	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error